Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state.

Literature DB >> 6835198

Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state.

D R Sibley, L C Mahan, I Creese.

Abstract

Mesh：

Substances：

Year: 1983 PMID： 6835198

Source DB: PubMed Journal: Mol Pharmacol ISSN： 0026-895X Impact factor: 4.436

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. T cell-mediated antigen presentation: a potential mechanism of infectious tolerance.

Authors: M D Mannie
Journal: Immunol Res Date: 2001 Impact factor: 2.829

Review 2. Advances and challenges in the search for D₂ and D₃ dopamine receptor-selective compounds.

Authors: Amy E Moritz; R Benjamin Free; David R Sibley
Journal: Cell Signal Date: 2017-07-14 Impact factor: 4.315

3. Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.

Authors: Mette Skinbjerg; Yoon Namkung; Christer Halldin; Robert B Innis; David R Sibley
Journal: Synapse Date: 2009-06 Impact factor: 2.562

Review 4. Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Authors: Jan-Peter van Wieringen; Jan Booij; Vladimir Shalgunov; Philip Elsinga; Martin C Michel
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2012-12-09 Impact factor: 3.000

Review 5. Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?

Authors: Mette Skinbjerg; David R Sibley; Jonathan A Javitch; Anissa Abi-Dargham
Journal: Biochem Pharmacol Date: 2011-09-16 Impact factor: 5.858

6. Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D₃ Dopamine Receptor Agonist.

Authors: Amy E Moritz; R Benjamin Free; Warren S Weiner; Emmanuel O Akano; Disha Gandhi; Ara Abramyan; Thomas M Keck; Marc Ferrer; Xin Hu; Noel Southall; Joseph Steiner; Jeffrey Aubé; Lei Shi; Kevin J Frankowski; David R Sibley
Journal: J Med Chem Date: 2020-05-12 Impact factor: 7.446

7. Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.

Authors: Ivonne Suridjan; Pablo Rusjan; Jean Addington; Alan A Wilson; Sylvain Houle; Romina Mizrahi
Journal: J Psychiatry Neurosci Date: 2013-03 Impact factor: 6.186

Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state.

Review 1. T cell-mediated antigen presentation: a potential mechanism of infectious tolerance.

Review 2. Advances and challenges in the search for D₂ and D₃ dopamine receptor-selective compounds.

3. Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.

Review 4. Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Review 5. Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?

6. Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D₃ Dopamine Receptor Agonist.

7. Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.

8. Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligand.

Review 9. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission.

10. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.

Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state.

Review 1. T cell-mediated antigen presentation: a potential mechanism of infectious tolerance.

Review 2. Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.

3. Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.

Review 4. Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications.

Review 5. Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?

6. Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.

7. Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.

8. Kinetic brain analysis and whole-body imaging in monkey of [11C]MNPA: a dopamine agonist radioligand.

Review 9. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission.

10. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.

Review 2. Advances and challenges in the search for D₂ and D₃ dopamine receptor-selective compounds.

6. Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D₃ Dopamine Receptor Agonist.